The Pennsylvania Supreme Court by a 6-1 vote ruled that an appellate court wrongly held that the claims of two men who took Risperdal in the 1990s when they were children and later sued in 2014 should ...
The FDA approved RISPERDAL (risperidone) for the treatment of schizophrenia in adolescents ages 13-17 and for the short-term treatment of bipolar mania associated with manic or mixed episodes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results